Clinical Trials in New York State

Showing 2081-2100 of 8,190 trials

An Evaluation of the Safety of CSF-1 in Presbyopic Subjects

NCT05393895

This is a multi-center, double-masked, vehicle-controlled study. The purpose of the study is to evaluate the safety of CSF-1 compared with vehicle in presbyopic subjects. Subjects will be treated for at least 6 weeks.

Presbyopia

Orasis Pharmaceuticals Ltd.178 participantsStarted Apr 2022

Newport Beach, California, United States • Petaluma, California, United States • Colorado Springs, Colorado, United States +9 more locations

Active Not RecruitingPhase 281 miles

Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer

NCT04533451

This trial studies the side effects of pembrolizumab with or without chemotherapy in treating patients with stage IV non-small cell lung cancer that has come back (recurrent) and has spread to other places in the body (advanced). Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Drugs used in chemotherapy, such as pemetrexed and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with or without chemotherapy may shrink the tumor in older patients with non-small cell lung cancer.

Metastatic Lung AdenocarcinomaMetastatic Lung Non-Small Cell CarcinomaRecurrent Lung Adenocarcinoma+4 more

Alliance for Clinical Trials in Oncology101 participantsStarted Nov 2020

Anchorage, Alaska, United States • Anchorage, Alaska, United States • Anchorage, Alaska, United States +502 more locations

An Evaluation of the Safety of CSF-1 in Presbyopic Subjects

Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer

Find Trials by Condition in New York State

A Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Stages of Alzheimer's Disease (AD)

Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)

Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas

A Dose-finding Study of CC-90009 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-risk Myelodysplastic Syndromes

ZZ06 in Adult Patients With Advanced Solid Tumor Malignancies

A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

Couples Motivational Interviewing to Reduce Drug Use and HIV Risk in Vulnerable Male Couples

A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)

ALL Adult Consortium Trial: Adult ALL Trial

AVID100 in Advanced Epithelial Carcinomas

Autosomal Dominant Polycystic Kidney Disease (ADPKD) Study

Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B

Shared-Decision Making for Hydroxyurea

AZD3470 as Monotherapy and in Combination With Anticancer Agents in Participants With Relapsed/Refractory Haematologic Malignancies.

D-PLEX 312 - Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection (SHIELD II)

Long-Term Follow-Up Gene Therapy Study for Achromatopsia CNGB3 and CNGA3

A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease

ProVIDE II Bridging Study